High IgSF11 expression in advanced glioma patients correlated with higher infiltration of immune cells, which would be weakly functional, due to the highly immuno-suppressive microenvironment (elevated expression of immune checkpoints and cytokines such as TGFβ). This evidence concerns the gene IGSF11 and central nervous system cancer.